Excess comorbidity prevalence and cost associated with functional dyspepsia in an employed population
- PMID: 21750928
- DOI: 10.1007/s10620-011-1822-8
Excess comorbidity prevalence and cost associated with functional dyspepsia in an employed population
Abstract
Background: Limited published data exist on the associated comorbid conditions with functional dyspepsia (FD).
Aims: This study aimed to assess the prevalence, services, and costs related to comorbid conditions associated with FD and the risk of having FD for each comorbid condition.
Methods: A retrospective database analysis was undertaken using payroll data and adjudicated claims from January 1, 2001, through December 31, 2004 among >300,000 employees. Employees with FD were compared to propensity-score-matched employees without FD (controls). Outcome measures included the prevalence, costs, and utilization of health services for comorbid conditions as defined by the Agency for Healthcare Research and Quality (AHRQ) and the odds ratios of having FD from a multivariate model.
Results: FD employees (N = 1,669) and a 50:1 matched control cohort (N = 83,450) were compared. Compared to matched controls, FD employees were more likely to have all major diagnostic categories. Moreover, 199/261 of the AHRQ's specific categories were more common in the FD cohort. Annual medical costs for the FD cohort were greater than for controls in 155/261 (59%) specific categories and significantly greater (P ≤ 0.05) in 76 categories (29%). Similarly, services were greater for 179/261 (69%) specific categories and significantly greater (P ≤ 0.05) in 110 categories (42%). In a multivariate model, esophageal disorders, gastritis and duodenitis, and abdominal pain were the most associated with having FD (odds ratios 3.8, 3.7, and 3.6, respectively). Only hypertension complications and disorders of the teeth and jaw were significantly negatively associated with FD.
Conclusion: There is unexplained excess comorbidity associated with FD which may be a major determining factor for excess healthcare services and costs.
Similar articles
-
Costs of physical and mental comorbidities among employees: a comparison of those with and without bipolar disorder.Curr Med Res Opin. 2006 Mar;22(3):443-52. doi: 10.1185/030079906X89748. Curr Med Res Opin. 2006. PMID: 16574028
-
Functional dyspepsia impacts absenteeism and direct and indirect costs.Clin Gastroenterol Hepatol. 2010 Jun;8(6):498-503. doi: 10.1016/j.cgh.2010.03.003. Epub 2010 Mar 19. Clin Gastroenterol Hepatol. 2010. PMID: 20304102
-
RISK FACTORS AND COMORBIDITY IN DIFFERENT TYPES OF FUNCTIONAL DYSPEPSIA: RETROSPECTIVE COHORT ANALYSIS.Georgian Med News. 2020 Oct;(307):104-108. Georgian Med News. 2020. PMID: 33270586
-
Clinical and epidemiological differences in functional dyspepsia between the East and the West.Neurogastroenterol Motil. 2016 Feb;28(2):167-74. doi: 10.1111/nmo.12657. Epub 2015 Aug 30. Neurogastroenterol Motil. 2016. PMID: 26331919 Review.
-
Systematic review with meta-analysis: post-infectious functional dyspepsia.Aliment Pharmacol Ther. 2015 Jan;41(2):177-88. doi: 10.1111/apt.13006. Epub 2014 Oct 27. Aliment Pharmacol Ther. 2015. PMID: 25348873 Review.
Cited by
-
Global trends in research related to functional dyspepsia and anxiety or depression over the past two decades: a bibliometric analysis.Front Neurosci. 2023 Nov 2;17:1218001. doi: 10.3389/fnins.2023.1218001. eCollection 2023. Front Neurosci. 2023. PMID: 38027507 Free PMC article.
-
Predictors of Co-occurring Cardiovascular and Gastrointestinal Disorders among Elderly with Osteoarthritis.Osteoarthr Cartil Open. 2021 Mar 11;3(2):100148. doi: 10.1016/j.ocarto.2021.100148. eCollection 2021 Jun. Osteoarthr Cartil Open. 2021. PMID: 36474979 Free PMC article.
-
Role of the duodenal microbiota in functional dyspepsia.Neurogastroenterol Motil. 2022 Nov;34(11):e14372. doi: 10.1111/nmo.14372. Epub 2022 Apr 11. Neurogastroenterol Motil. 2022. PMID: 35403776 Free PMC article. Review.
-
Validation of the Short-Form Esophageal Hypervigilance and Anxiety Scale.Clin Gastroenterol Hepatol. 2022 Feb;20(2):e64-e73. doi: 10.1016/j.cgh.2020.12.021. Epub 2021 Jan 14. Clin Gastroenterol Hepatol. 2022. PMID: 33348046 Free PMC article.
-
Clinical study on post evaluation after listing of Qizhi Weitong granules: Study protocol clinical trial (SPIRIT compliant).Medicine (Baltimore). 2020 Apr;99(16):e19758. doi: 10.1097/MD.0000000000019758. Medicine (Baltimore). 2020. PMID: 32311977 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
